公开(公告)号：US20210009700A1

公开(公告)日：2021-01-14

申请号：US16911806

申请日：2020-06-25

Applicant: Five Prime Therapeutics, Inc.

Inventor： Robert Sikorski ,  Julie Hambleton ,  Nilacantan Sankar

IPC: C07K16/28

Abstract: Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.

公开(公告)号：US10730949B2

公开(公告)日：2020-08-04

申请号：US16015371

申请日：2018-06-22

Applicant: Five Prime Therapeutics, Inc.

Inventor： Robert Sikorski ,  Julie Hambleton ,  Nilacantan Sankar

IPC: C07K16/28 ,  A61K39/00

Abstract: Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.

公开(公告)号：US20190119390A1

公开(公告)日：2019-04-25

申请号：US16015371

申请日：2018-06-22

Applicant: Five Prime Therapeutics, Inc.

Inventor： Robert Sikorski ,  Julie Hambleton ,  Nilacantan Sankar

IPC: C07K16/28

Abstract: Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.

公开(公告)号：US10040858B2

公开(公告)日：2018-08-07

申请号：US14976346

申请日：2015-12-21

Applicant: FIVE PRIME THERAPEUTICS, INC.

Inventor： Robert Sikorski ,  Julie Hambleton ,  Nilacantan Sankar

IPC: C07K16/28 ,  A61K39/395 ,  A61K39/00

Abstract: Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.